Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections

BACKGROUND: Current prevention options for upper respiratory infections (URIs) are not optimal. We conducted a randomized, double-blinded, placebo-controlled pilot clinical trial to evaluate the safety and efficacy of ARMS-I™ (currently marketed as Halo™) in the prevention of URIs. METHODS: ARMS-I i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Pranab K., Esper, Frank, Buchheit, Ken, Arters, Karen, Adkins, Ina, Ghannoum, Mahmoud A., Salata, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237564/
https://www.ncbi.nlm.nih.gov/pubmed/28088167
http://dx.doi.org/10.1186/s12879-016-2177-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237564/
https://www.ncbi.nlm.nih.gov/pubmed/28088167
http://dx.doi.org/10.1186/s12879-016-2177-8

Ejemplares similares